Figure 5From: Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinibKaplan-Meier estimate of time to progression (TTP) and overall survival (OS) in patients stratified by above/below median ratio to baseline levels of sKIT (A and B), sVEGF-A (C and D), and VEGF-C (E and F) at post-baseline time points. Graphs A, C, and E show TTP and graphs B, D, and F show OS. C, cycle; D, day.Back to article page